STP-125G

N/A

Report date: 2024/07/15 14:17:43

NME

Base Information

Drug NameSTP-125G

Drug Alias NameGalAheadSTP-125G

ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Small molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionApolipoprotein C-III inhibitors

TargetsApolipoprotein C-III

Therapy Area/IndicationsHypertriglyceridemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesSirnaomics

China Registration ClassN/A

Develop Information

Active CompaniesSirnaomics

Inactive CompaniesN/A

Active IndicationsHypertriglyceridemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A